Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.58 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.42 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27896983 | 1.00 | MAPT (0.58) | MAPTABCC4TBXAS1PTPN1LMNA | |
| SCHEMBL9281262 | 1.00 | MAPT (0.58) | MAPTABCC4TBXAS1PTPN1LMNA | |
| SCHEMBL27957677 | 1.00 | MAPT (0.58) | MAPTABCC4TBXAS1PTPN1LMNA | |
| SCHEMBL2491627 | 1.00 | MAPT (0.58) | MAPTABCC4TBXAS1PTPN1LMNA | |
| SCHEMBL2854551 | 1.00 | MAPT (0.58) | MAPTABCC4TBXAS1PTPN1LMNA | |
| SCHEMBL5378939 | 1.00 | MAPT (0.58) | MAPTABCC4TBXAS1PTPN1LMNA | |
| SCHEMBL5378935 | 1.00 | MAPT (0.58) | MAPTABCC4TBXAS1PTPN1LMNA | |
| SCHEMBL15284588 | 1.00 | MAPT (0.58) | MAPTABCC4TBXAS1PTPN1LMNA | |
| SCHEMBL9735318 | 1.00 | MAPT (0.58) | MAPTABCC4TBXAS1PTPN1LMNA | |
| SCHEMBL9955539 | 1.00 | MAPT (0.58) | MAPTABCC4TBXAS1PTPN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-61109752-A | — | — | None | — | — | JP | disclosed |
| US-20150045409-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-02-12 | — | — | US | disclosed |
| EP-2813493-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | Sumitomo Chemical Company Limited (JP) | 2014-12-17 | — | — | EP | disclosed |
| EP-1221836-B1 | NOVEL BISEXUAL ATTRACTANTS, AGGREGANTS AND ARRESTANTS FOR ADULTS AND LARVAE OF CODLING MOTH AND OTHER SPECIES OF LEPIDOPTERA | TRECE INC (US) | 2010-01-20 | — | — | EP | disclosed |
| US-4902334-A | HERBICIDES | TEIJIN LIMITED (JP) | 1990-02-20 | — | — | US | disclosed |
| JP-S61109752-A | PLANT METABOLISM CONTROLLING AGENT, ITS USE, AND BETA-ALKYNYL-SUBSTITUTED ALPHA,BETA-UNSATURATED CARBOXYLIC ACID | TEIJIN LTD | 1986-05-28 | — | — | JP | disclosed |
| EP-0149034-A2 | Regulation of plant metalbolism by alpha,beta- or beta,gamma-unsaturated carboxylic acids or derivatives thereof | TEIJIN LIMITED (JP) | 1985-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150045409-A1 | AMIDE COMPOUND AND USE THEREOF FOR PEST CONTROL | ARG1, ACOT7, RPS8 | MAPT 4123/4885ABCC4 1590/4885TBXAS1 2410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.